Page last updated: 2024-09-03

2-nitroimidazole-1-methylacetohydroxamate and ku 2285

2-nitroimidazole-1-methylacetohydroxamate has been researched along with ku 2285 in 1 studies

Compound Research Comparison

Studies
(2-nitroimidazole-1-methylacetohydroxamate)
Trials
(2-nitroimidazole-1-methylacetohydroxamate)
Recent Studies (post-2010)
(2-nitroimidazole-1-methylacetohydroxamate)
Studies
(ku 2285)
Trials
(ku 2285)
Recent Studies (post-2010) (ku 2285)
8001920

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, M; Iwai, H; Murata, R; Oya, N; Shibamoto, Y; Shibata, T; Sugiyama, T1

Other Studies

1 other study(ies) available for 2-nitroimidazole-1-methylacetohydroxamate and ku 2285

ArticleYear
KIN-804 vs. KU-2285 as a radiosensitizer for clinical use.
    International journal of radiation oncology, biology, physics, 1994, Jun-15, Volume: 29, Issue:3

    Topics: Animals; Carcinoma, Squamous Cell; Chromosome Aberrations; Female; Humans; Hydroxamic Acids; Mice; Mice, Inbred C3H; Micronucleus Tests; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents

1994